Home > Financial Ratios > TATVA CHINTAN PHARMA CHEM

TATVA CHINTAN PHARMA CHEM
Core EBITDA Growth

    Back to All Ratios
TATVA CHINTAN PHARMA CHEM is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for TATVA CHINTAN PHARMA CHEM
Please provide your vote to see the results

TATVA CHINTAN PHARMA CHEM Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 14.10-43.4063.5226.8663.71

What is the latest Core EBITDA Growth ratio of TATVA CHINTAN PHARMA CHEM ?

The latest Core EBITDA Growth ratio of TATVA CHINTAN PHARMA CHEM is 14.10 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202414.10
Mar2023-43.40
Mar202263.52
Mar202126.86
Mar202063.71

How is Core EBITDA Growth of TATVA CHINTAN PHARMA CHEM Trending?

Years Core EBITDA Growth % Change
Mar2024 14.1
Positive
Mar2023 -43.4
Negative
Mar2022 63.52
136.49
Mar2021 26.86
-57.84
Mar2020 63.71 -

Other Financial Ratios of TATVA CHINTAN PHARMA CHEM


Compare Core EBITDA Growth ratio of peers of TATVA CHINTAN PHARMA CHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TATVA CHINTAN PHARMA CHEM ₹2,180.4 Cr -2.3% -1.4% -17.8% Stock Analytics
PIDILITE INDUSTRIES ₹150,884.0 Cr -3.2% -1.5% -5.1% Stock Analytics
SOLAR INDUSTRIES INDIA ₹137,631.0 Cr -7.9% -9.7% 24.9% Stock Analytics
SRF ₹93,905.9 Cr -3.6% 2.3% 32.5% Stock Analytics
GUJARAT FLUOROCHEMICALS ₹37,490.2 Cr -0.7% -8.7% 5.2% Stock Analytics
GODREJ INDUSTRIES ₹36,942.2 Cr -4.9% -14.3% 20.3% Stock Analytics


TATVA CHINTAN PHARMA CHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TATVA CHINTAN PHARMA CHEM

-2.3%

-1.4%

-17.8%

SENSEX

-1.4%

0.7%

2.4%


You may also like the below Video Courses